[go: up one dir, main page]

FR2983077B1 - Seringue - Google Patents

Seringue Download PDF

Info

Publication number
FR2983077B1
FR2983077B1 FR1350671A FR1350671A FR2983077B1 FR 2983077 B1 FR2983077 B1 FR 2983077B1 FR 1350671 A FR1350671 A FR 1350671A FR 1350671 A FR1350671 A FR 1350671A FR 2983077 B1 FR2983077 B1 FR 2983077B1
Authority
FR
France
Prior art keywords
syringe
relates
present
small volume
ophthalmic injections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
FR1350671A
Other languages
English (en)
Other versions
FR2983077A1 (fr
Inventor
Juergen Sigg
Christophe Royer
Andrew Mark Bryant
Heinrich Martin Buettgen
Marie Picci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48051683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2983077(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE202012011016U external-priority patent/DE202012011016U1/de
Priority claimed from AU2013100070A external-priority patent/AU2013100070B4/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of FR2983077A1 publication Critical patent/FR2983077A1/fr
Application granted granted Critical
Publication of FR2983077B1 publication Critical patent/FR2983077B1/fr
Revoked legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A61M2005/3104—Caps for syringes without needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
    • A61M2005/3139—Finger grips not integrally formed with the syringe barrel, e.g. using adapter with finger grips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M2005/31508—Means for blocking or restricting the movement of the rod or piston provided on the piston-rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0612—Eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M5/31513—Piston constructions to improve sealing or sliding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une seringue, en particulier une seringue de petit volume telle qu'une seringue appropriée pour les injections ophtalmiques.
FR1350671A 2012-07-03 2013-01-25 Seringue Revoked FR2983077B1 (fr)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
EP12174860 2012-07-03
EP12174860.2 2012-07-03
EP12189649.2 2012-10-23
EP12189649 2012-10-23
DE202012011016U DE202012011016U1 (de) 2012-07-03 2012-11-16 Aflibercept-Spritze
AU2012101678A AU2012101678B4 (en) 2012-07-03 2012-11-16 Use of device
AU2012101677A AU2012101677B4 (en) 2012-07-03 2012-11-16 Device
DE202012011259U DE202012011259U1 (de) 2012-07-03 2012-11-23 Bevacizumab-Spritze
DE202012011260U DE202012011260U1 (de) 2012-07-03 2012-11-23 Ranibizumab-Spritze
EP12195360.8 2012-12-03
EP12195360 2012-12-03
AU2013100070A AU2013100070B4 (en) 2012-07-03 2013-01-23 Use of device
DE201320000688 DE202013000688U1 (de) 2012-07-03 2013-01-23 Glas-Spritze
AU2013100071A AU2013100071C4 (en) 2012-07-03 2013-01-23 Device

Publications (2)

Publication Number Publication Date
FR2983077A1 FR2983077A1 (fr) 2013-05-31
FR2983077B1 true FR2983077B1 (fr) 2018-09-14

Family

ID=48051683

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1350671A Revoked FR2983077B1 (fr) 2012-07-03 2013-01-25 Seringue

Country Status (39)

Country Link
US (1) US9220631B2 (fr)
EP (5) EP3381444B1 (fr)
JP (2) JP5744927B2 (fr)
KR (7) KR102487296B1 (fr)
CN (4) CN104427972A (fr)
AR (1) AR090059A1 (fr)
AU (1) AU2013201624A1 (fr)
BR (2) BR112014032990B1 (fr)
CA (1) CA2803566A1 (fr)
CH (1) CH706741B1 (fr)
CL (1) CL2014003619A1 (fr)
CO (1) CO7151483A2 (fr)
CY (2) CY1121497T1 (fr)
DE (1) DE202013000688U1 (fr)
DK (4) DK3656373T3 (fr)
EA (1) EA031583B1 (fr)
EC (1) ECSP15004005A (fr)
ES (4) ES2906812T3 (fr)
FR (1) FR2983077B1 (fr)
GT (1) GT201400300A (fr)
HR (4) HRP20220083T1 (fr)
HU (3) HUE057746T2 (fr)
IL (2) IL236296B (fr)
JO (2) JOP20200175A1 (fr)
LT (4) LT3656373T (fr)
MA (1) MA37740B2 (fr)
MX (1) MX358323B (fr)
MY (1) MY164536A (fr)
NZ (1) NZ702980A (fr)
PE (1) PE20150196A1 (fr)
PH (1) PH12014502785B1 (fr)
PL (4) PL3685826T3 (fr)
PT (1) PT2869813T (fr)
SG (1) SG11201408261UA (fr)
SI (4) SI3656373T1 (fr)
TN (1) TN2014000517A1 (fr)
TW (1) TWI632920B (fr)
WO (1) WO2014005728A1 (fr)
ZA (1) ZA201409411B (fr)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2633574T3 (es) 2005-03-25 2017-09-22 Regeneron Pharmaceuticals, Inc. Formulaciones de antagonistas de VEGF
PT2944306T (pt) 2006-06-16 2021-02-15 Regeneron Pharma Formulações antagonistas de vegf adequadas para administração intravitreal
US11624115B2 (en) 2010-05-12 2023-04-11 Sio2 Medical Products, Inc. Syringe with PECVD lubrication
US9878101B2 (en) 2010-11-12 2018-01-30 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
CA2855353C (fr) 2011-11-11 2021-01-19 Sio2 Medical Products, Inc. Revetement de passivation, de protection de ph ou a pouvoir lubrifiant pour conditionnement pharmaceutique, processus et appareil de revetement
US11116695B2 (en) 2011-11-11 2021-09-14 Sio2 Medical Products, Inc. Blood sample collection tube
LT3679922T (lt) 2012-06-01 2021-10-25 Novartis Ag Švirkštas
US20150297800A1 (en) 2012-07-03 2015-10-22 Sio2 Medical Products, Inc. SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS
JOP20200175A1 (ar) 2012-07-03 2017-06-16 Novartis Ag حقنة
US9764093B2 (en) 2012-11-30 2017-09-19 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
CN105392916B (zh) 2013-03-11 2019-03-08 Sio2医药产品公司 涂布包装材料
WO2014165105A2 (fr) * 2013-03-13 2014-10-09 Rush Universiyt Medical Center Dispositif de distribution et système de stockage pour l'administration oropharyngée de colostrum et lait maternels
US20140350518A1 (en) * 2013-05-23 2014-11-27 Allergan, Inc. Syringe extrusion accessory
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
EP3122917B1 (fr) 2014-03-28 2020-05-06 SiO2 Medical Products, Inc. Revêtements antistatiques pour des récipients en plastique
EP3492495A1 (fr) * 2014-05-12 2019-06-05 Formycon AG Seringue en plastique préremplie contenant un antagoniste de vegf
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
TWI738632B (zh) 2014-11-07 2021-09-11 瑞士商諾華公司 穩定的含有高濃度抗vegf抗體之蛋白質溶液調配物
EP3058974A1 (fr) 2015-02-19 2016-08-24 Sanofi-Aventis Deutschland GmbH Dispositif d'injection avec dispositif supplémentaire
EP3274026B1 (fr) 2015-03-23 2024-10-02 Sanofi-Aventis Deutschland GmbH Méthode pour augmenter la précision de dosage d'un dispositif d'injection
MA41906A (fr) 2015-04-10 2018-02-13 Dompe Farm Spa Dispositif de distribution de gouttes oculaires
RU2734958C2 (ru) * 2015-11-18 2020-10-26 Формикон Аг Предварительно заполненная фармацевтическая упаковка, содержащая жидкий состав на основе антагониста vegf
CA3005132A1 (fr) * 2015-11-18 2017-05-26 Sio2 Medical Products, Inc. Seringue revetue pour des formulations ophtalmiques contenant un antagoniste du vegf
WO2017085253A1 (fr) * 2015-11-18 2017-05-26 Formycon Ag Seringue en plastique préremplie contenant un antagoniste du facteur de croissance de l'endothélium vasculaire (vegf)
CA3007276C (fr) 2015-12-03 2021-12-28 Regeneron Pharmaceuticals, Inc. Utilisation de l'inhibiteur de vegf pour traiter la degenerescence maculaire dans une population de patients
AU2016381964B2 (en) 2015-12-30 2024-02-15 Kodiak Sciences Inc. Antibodies and conjugates thereof
US11707577B2 (en) 2016-04-15 2023-07-25 Santen Pharmaceutical Co., Ltd. Accurate, precise microliter dosing syringe
US20170349313A1 (en) * 2016-06-01 2017-12-07 Centurion Medical Products Corporation Methods for manufacturing non-glass prefilled syringes
US10774229B2 (en) 2016-06-17 2020-09-15 Kao Corporation Aqueous ink
TWI737742B (zh) * 2016-06-22 2021-09-01 德商梅茲製藥有限兩合公司 肉毒桿菌毒素的預填充式注射器系統、具有其之套組以及其之使用
ITUA20162072A1 (it) * 2016-06-30 2017-12-30 Platinum Corp Srl Dropper a volume controllato
JP6788677B2 (ja) 2016-08-22 2020-11-25 株式会社Ｆｕｊｉ 過酸化水素水の製造方法及び殺菌対象物の殺菌方法
US10537683B2 (en) 2016-11-03 2020-01-21 Johnson & Johnson Surgical Vision, Inc. Syringe finger grip
IL315639A (en) 2017-03-27 2024-11-01 Regeneron Pharma Sterilization method
CN111787915A (zh) 2017-04-12 2020-10-16 尤里根制药股份有限公司 注射器中包含局部麻醉剂、缓冲剂和糖胺聚糖的稳定性提高的制品
AU2018262454A1 (en) 2017-05-05 2019-10-10 Novartis Ag A syringe comprising a collapsible plunger
EP3630043A1 (fr) 2017-05-24 2020-04-08 Formycon AG Conditionnements pharmaceutiques pré-remplis stérilisables comprenant une formulation liquide d'un antagoniste du vegf
CA3063995A1 (fr) 2017-05-24 2018-11-29 Sio2 Medical Products, Inc. Conditionnement pharmaceutique sterilisable pour formulations ophtalmiques
WO2018232408A1 (fr) 2017-06-16 2018-12-20 Credence Medsystems, Inc. Système et procédé pour seringue de sécurité
US11590175B2 (en) 2017-08-23 2023-02-28 Merakris Therapeutics Llc Compositions containing amniotic components and methods for preparation and use thereof
FR3072297B1 (fr) * 2017-10-17 2023-05-12 Edix Sa Dispositif d'injection manuelle
CN117065152A (zh) 2017-12-13 2023-11-17 里珍纳龙药品有限公司 用于精确剂量输送的装置和方法
CN111670059B (zh) 2018-02-02 2023-09-05 豪夫迈·罗氏有限公司 预填充式注射器和对预填充式注射器进行灭菌的方法
CN112203679A (zh) 2018-03-02 2021-01-08 科达制药股份有限公司 Il-6抗体及其融合构建体和缀合物
JP2021520868A (ja) * 2018-04-09 2021-08-26 エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド 伸縮自在のプランジャーアセンブリ
EP4039295B1 (fr) * 2018-04-24 2025-03-12 W. L. Gore & Associates, Inc. Dispositifs d'administration médicale à perméation d'oxygène inhibée
BR112020022610A2 (pt) 2018-05-10 2021-02-09 Regeneron Pharmaceuticals, Inc. proteína de fusão de receptor de vegf de alta concentração que contém formulações
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
US20210260300A1 (en) * 2018-06-01 2021-08-26 Sun Pharma Advanced Research Company Limited An injection device
US20220000661A1 (en) * 2018-10-26 2022-01-06 Singapore Health Services Pte Ltd Device and method for opthalmic extraction and injection
CA3119455C (fr) 2018-11-13 2024-07-02 Credence Medsystems, Inc. Systeme et procede d'injection de site multiple
WO2020109343A1 (fr) 2018-11-29 2020-06-04 F. Hoffmann-La Roche Ag Polythérapie pour le traitement de la dégénérescence maculaire
WO2020109344A1 (fr) 2018-11-29 2020-06-04 F. Hoffmann-La Roche Ag Dispositif d'administration oculaire pour oligonucléotides antisens
MX2021007393A (es) 2018-12-18 2021-09-23 Novartis Ag Formulacion de solucion de proteinas que contiene una alta concentracion de un anticuerpo anti-vegf.
CN110721026A (zh) * 2018-12-21 2020-01-24 南通市第一人民医院 一种眼科手术用取硅油装置防滑层的制备方法
EP3689397B1 (fr) * 2019-01-31 2025-04-23 SCHOTT Pharma Schweiz AG Corps de seringue, seringue et dispositif d'injection permettant d'injecter un milieu à haute viscosité
GB201902355D0 (en) * 2019-02-21 2019-04-10 New Injection Systems Ltd Modular auto injector
FR3093004B1 (fr) * 2019-02-21 2023-04-07 Dev Techniques Plastiques Procede de preparation d’une seringue
KR20220012220A (ko) 2019-02-28 2022-02-03 메라크리스 테라퓨틱스 엘엘씨 양수 유래 세포외 소포체 및 상처 치유를 위한 이의 용도
ES2902983T3 (es) 2019-03-29 2022-03-30 Kortuc Inc Jeringa precargada con una solución de peróxido de hidrógeno que tiene una excelente capacidad de preservación del peróxido de hidrógeno debido al aceite de silicona (composición de aceite que contiene dicho aceite de silicona)
EP3955994A1 (fr) 2019-04-18 2022-02-23 Boehringer Ingelheim International GmbH Dispositif d'administration pour l'administration d'un fluide
CN118718179A (zh) 2019-06-05 2024-10-01 里珍纳龙药品有限公司 用于精确剂量递送的装置及方法
AU2020320222A1 (en) * 2019-08-01 2022-03-03 Gennova Biopharmaceuticals Limited Opthalmic composition of Bevacizumab
MX2022002355A (es) * 2019-09-03 2022-04-06 Amgen Inc Dispositivo de inyeccion para suministro de farmacos y envase para el dispositivo de inyeccion.
WO2021046245A1 (fr) * 2019-09-04 2021-03-11 University Of Massachusetts Plateforme de vecteur de virus adéno-associé pour l'administration de kh902 (conbercept) et ses utilisations
CA3150482A1 (fr) 2019-09-16 2021-03-25 Amgen Inc. Methode de sterilisation externe d'un dispositif d'administration de medicament
CA3157509A1 (fr) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Procedes de traitement d'un trouble oculaire
JP7779833B2 (ja) 2019-11-14 2025-12-03 コングルーエンス メディカル ソリューションズ，エルエルシー 可変投薬注射器
WO2021108530A1 (fr) * 2019-11-26 2021-06-03 University Of Massachusetts Virus adéno-associé recombinant pour l'administration de kh902 (conbercept) et utilisations associées
EP4069164A2 (fr) 2019-12-05 2022-10-12 F. Hoffmann-La Roche AG Seringue et procédé de test d'étanchéité
JP7640549B2 (ja) * 2019-12-12 2025-03-05 ノバルティス アーゲー 注射デバイス及び注射溶液移し替えシステム
EP4098298B1 (fr) * 2020-03-24 2025-08-27 TERUMO Kabushiki Kaisha Poignée de cylindre de seringue, ensemble cylindre et seringue
US11883635B2 (en) 2020-06-17 2024-01-30 Credence MedSystems System and method for microdose injection
EP4237043A1 (fr) 2020-10-30 2023-09-06 Boehringer Ingelheim International GmbH Dispositif d'administration destiné, en particulier, à l'administration intravitréenne d'un fluide
CA3201808A1 (fr) 2020-12-01 2022-06-09 Boehringer Ingelheim International Gmbh Dispositif d'administration destine, en particulier, a l'administration intravitreenne d'un fluide
KR102720956B1 (ko) 2020-12-15 2024-10-24 삼천당제약주식회사 안과용 제형을 포함하는 시린지
CN116782969A (zh) * 2020-12-29 2023-09-19 W.L.戈尔及同仁股份有限公司 具有薄膜润滑剂的药物注射止挡件
JP2024515616A (ja) * 2021-04-15 2024-04-10 アルテオジェン・インコーポレイテッド 低容量薬液充填の事前充填型注射器及びその製造方法
EP4441414A1 (fr) * 2021-12-01 2024-10-09 Sanofi Winthrop Industrie Navette lubrifiante
CN114146220B (zh) 2022-02-10 2022-04-29 中国远大集团有限责任公司 一种包含无菌pcl微球的美容产品
EP4389176A1 (fr) 2022-12-20 2024-06-26 W. L. Gore & Associates, Inc. Bouchons de seringue à faible force d'insertion, ensembles et procédés associés
EP4480517A1 (fr) 2023-06-20 2024-12-25 Ypsomed AG Auto-injecteur pour injection intravitréenne
CA3237624A1 (fr) * 2023-07-28 2025-04-24 Genentech, Inc. Nouvelles utilisations d'omalizumab
CN117942456B (zh) * 2024-03-27 2024-07-12 山东永聚医药科技股份有限公司 缓释型非牛顿流体制剂用预灌封注射器及其制备工艺
KR102828906B1 (ko) * 2024-11-18 2025-07-04 주식회사 비에스리서치 실리콘 오일이 미적용된 프리필드 시린지

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31789A (en) 1861-03-26 Bread-slicebi
DE2629557B2 (de) 1976-07-01 1980-05-14 Paul E. Dr.Med. 8000 Muenchen Doerr Einmai-Injektionsspritze
JPH0747045B2 (ja) * 1986-10-15 1995-05-24 株式会社大協精工 積層した注射器用滑栓
US4946441A (en) 1988-07-21 1990-08-07 Maurice Laderoute Limited use hypodermic syringe
JPH0725963Y2 (ja) 1989-11-06 1995-06-14 清坤 曽 緊急避難装置
DE69127614T2 (de) * 1990-11-17 1998-04-09 Santen Pharma Co Ltd Spritzenzylinder mit zwei kammern
US5236604A (en) * 1991-05-29 1993-08-17 Sherwood Medical Company Serum separation blood collection tube and the method of using thereof
JP3186422B2 (ja) 1993-05-14 2001-07-11 武田薬品工業株式会社 プラスチゾル
US5405326A (en) 1993-08-26 1995-04-11 Habley Medical Technology Corporation Disposable safety syringe with retractable shuttle for luer lock needle
US5795337A (en) 1994-02-14 1998-08-18 Becton Dickinson And Company Syringe assembly and syringe stopper
US5688252A (en) 1994-09-30 1997-11-18 Takeda Chemical Industries, Ltd. Syringe
US5667495A (en) 1995-04-21 1997-09-16 Becton Dickinson France S.A. Backstop device for a syringe
US5607400A (en) * 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
DE19622283A1 (de) 1996-05-23 1997-11-27 Schering Ag Verfahren zur terminalen Sterilisierung von befüllten Spritzen
JP4078406B2 (ja) * 1997-01-22 2008-04-23 有限会社コーキ・エンジニアリング 注射器のシリンダの製造方法
ES2273415T3 (es) 1997-04-07 2007-05-01 Genentech, Inc. Anticuerpos anti-vegf.
JP3387775B2 (ja) * 1997-05-22 2003-03-17 株式会社大協精工 注射器用密封栓及びプレフィルド注射器
US6200627B1 (en) * 1998-03-17 2001-03-13 Becton, Dickinson And Company Low silicone glass prefillable syringe
CA2329707A1 (fr) * 1998-04-30 1999-11-04 Abbott Laboratories Ensemble seringue
USD430015S (en) 1998-06-11 2000-08-29 Pharmacia & Upjohn Ab Blister pack for a syringe
JP2001104480A (ja) * 1999-10-05 2001-04-17 Daikyo Seiko Ltd プラスチック製プレフィルド注射器の密封に使用するゴム製ピストン
JP2001340455A (ja) 2000-05-31 2001-12-11 Yoshino Kogyosho Co Ltd シリンジ容器
JP2002177388A (ja) 2000-12-15 2002-06-25 Daikyo Seiko Ltd 医薬・医療用既充填注射器
JP2002241264A (ja) * 2001-02-19 2002-08-28 Asahi Kasei Corp エルカトニンのプレフィルドシリンジ製剤
AU2002357520A1 (en) * 2001-12-27 2003-07-15 Menicon Co., Ltd. Cartridge syringe, cartridge and ophthalmologic syringe set equipped with the cartridge syringe
JP4141156B2 (ja) 2002-03-15 2008-08-27 日本ベクトン・ディッキンソン株式会社 プランジャ後退制限機構付きプレフィルドシリンジ
US6688252B1 (en) 2002-12-11 2004-02-10 Gary Caravella Boat cover
JP2006519070A (ja) 2003-02-27 2006-08-24 バクスター・インターナショナル・インコーポレイテッド 注射器のためのピストンアセンブリ
JP2004313369A (ja) 2003-04-15 2004-11-11 Menicon Co Ltd カートリッジ注入器、カートリッジ及び該注入器を備えた眼科用注入器セット
FR2855413B1 (fr) 2003-05-26 2005-12-30 Becton Dickinson France Seringue pre-remplie avec coiffe anti effraction
WO2005069831A2 (fr) * 2004-01-12 2005-08-04 Iscience Surgical Corporation Injecteurs de produits visqueux
US8124207B2 (en) 2004-03-02 2012-02-28 Sakhrani Vinay G Article with lubricated surface and method
JP4680997B2 (ja) 2004-06-08 2011-05-11 ツェンドゥー カンホン バイオテクノロジーズ カンパニー リミテッド 血管新生を阻害するキメラタンパク質およびその利用
NZ590132A (en) * 2004-10-21 2012-03-30 Genentech Inc Dosage regime for treating intraocular neovascular diseases with VEGF
US7303748B2 (en) * 2005-02-02 2007-12-04 Regeneron Pharmaceuticals, Inc. Method of treating eye injury with local administration of a VEGF inhibitor
EP1888150A1 (fr) 2005-05-31 2008-02-20 Baxter International Inc. Cylindre creux en polypropylene pourvu d'un piston en caoutchouc coulissant
US20060293270A1 (en) * 2005-06-22 2006-12-28 Adamis Anthony P Methods and compositions for treating ocular disorders
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
FR2890316B1 (fr) * 2005-09-02 2007-10-05 Aguettant Soc Par Actions Simp Seringue destinee a etre remplie puis sterilisee par autoclavage a la vapeur.
CA2622573A1 (fr) * 2005-09-16 2007-03-29 (Osi) Eyetech, Inc. Seringue oculaire
WO2007035623A1 (fr) 2005-09-17 2007-03-29 Technology Group Northwest Inc. Systeme et methode pour une protection dirigee contre des attaques d'injection de code dans un dispositif informatique
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
CN101365456A (zh) * 2005-10-14 2009-02-11 爱尔康公司 治疗原发性和继发性形式的青光眼的方法
AT502791B1 (de) * 2006-04-06 2007-05-15 Pharma Consult Ges M B H & Co Injektionsspritze
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
EP2012826B1 (fr) * 2006-05-04 2016-04-13 Fovea Pharmaceuticals Combinaison comprenant un inhibiteur de vegf et une protease a serine pour le traitement des maladies néovasculaires
PT2944306T (pt) * 2006-06-16 2021-02-15 Regeneron Pharma Formulações antagonistas de vegf adequadas para administração intravitreal
JP4131001B2 (ja) 2006-07-28 2008-08-13 大成化工株式会社 定量吐出装置
CN200973886Y (zh) * 2006-11-20 2007-11-14 骆忠林 一种注射器
WO2008077155A1 (fr) 2006-12-21 2008-06-26 Genentech, Inc. Stérilisation d'objets contenant des molécules biologiques
US8529521B2 (en) 2007-04-23 2013-09-10 Ultimed Inc. Low-dosage syringe
CN100563736C (zh) * 2007-06-02 2009-12-02 丁锐 一次性防刺伤注射器
AU2008261631B2 (en) 2007-06-12 2013-06-06 Becton, Dickinson And Company Syringe with disabling mechanism
ES2376761T3 (es) * 2007-07-31 2012-03-16 Al.Chi.Mi.A. S.R.L. Método para realizar un dispositivo para tratamientos oftálmicos
WO2009030975A1 (fr) 2007-09-03 2009-03-12 Becton Dickinson France Dispositif médical comprenant une chambre siliconée et un moyen de fermeture pourvu d'un revêtement
WO2009030976A1 (fr) 2007-09-03 2009-03-12 Becton Dickinson France Dispositif médical et revêtement lisse pour ce dispositif
DE102008005938A1 (de) 2008-01-24 2009-07-30 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Vorgefüllte Spritze und Verfahren zum Verpacken einer Spritze
US20100310309A1 (en) 2008-01-24 2010-12-09 Meflex Telecontrol Gmbh & Co. Kg Terminus cap for a drive cable, drive cable, method for the production of a terminus cap, and method for the production of drive cable
SG10201402265YA (en) 2008-02-07 2014-08-28 Amgen Inc Stabilized protein compositions
CN102065939B (zh) * 2008-06-17 2013-06-19 电气化学工业株式会社 注射器
WO2009158613A1 (fr) 2008-06-26 2009-12-30 West Pharmaceutical Services, Inc. Procédé de revêtement de polyxylylène sur des surfaces fluoropolymères et dispositifs ainsi enduits
US8221353B2 (en) 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
CN102272148A (zh) 2008-11-03 2011-12-07 分子组合公司 抑制vegf-a受体相互作用的结合蛋白
US20110276005A1 (en) 2008-12-03 2011-11-10 Taisei Kako Co., Ltd. Syringe
EP3028707A1 (fr) * 2009-05-01 2016-06-08 Ophthotech Corporation Verfahren zur behandlung oder prävention von augenerkrankungen
AR076796A1 (es) 2009-05-28 2011-07-06 Glaxo Group Ltd Proteinas de union al antigeno. composicion farmaceutica. uso. procedimiento.
EP2266647A1 (fr) * 2009-06-25 2010-12-29 Sanofi-Aventis Deutschland GmbH Mécanisme d'entraînement pour dispositif d'administration de médicament
AR078060A1 (es) 2009-07-14 2011-10-12 Novartis Ag Descontaminacion de superficie de contenedores previamente llenados en empaque secundario
EP3725348A1 (fr) 2009-10-29 2020-10-21 W.L. Gore & Associates Inc. Capuchon de seringue revêtu d'eptfe
CN201578690U (zh) 2010-01-21 2010-09-15 王建友 一种注射器
US9408746B2 (en) 2010-03-31 2016-08-09 Ocuject, Llc Device and method for intraocular drug delivery
CA2795096C (fr) 2010-03-31 2021-10-26 Ocuject, Llc Dispositif et procede pour administrer un medicament par voie intra-oculaire
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制ｖｅｇｆ－ａ受體交互作用的經修飾結合性蛋白質
JP2012045046A (ja) 2010-08-24 2012-03-08 Gc Corp 歯科用シリンジ
FR2966044B1 (fr) 2010-10-18 2012-11-02 Sanofi Pasteur Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium
US10034981B2 (en) 2011-03-01 2018-07-31 Terumo Kabushiki Kaisha Syringe and syringe assembly
PL2701773T3 (pl) 2011-04-25 2019-09-30 Icon Bioscience, Inc. Prowadniki dawki do strzykawki iniekcyjnej
US20130012918A1 (en) 2011-07-07 2013-01-10 Gary Foster Steady grip ophthalmic surgical syringe and method
EP4218862A1 (fr) 2011-09-27 2023-08-02 Becton Dickinson France Dispositif d'injection médical comprenant un revêtement lubrifiant
US9421129B2 (en) 2012-04-02 2016-08-23 Ocuject, Llc Intraocular delivery devices and methods therefor
US10780228B2 (en) 2012-05-07 2020-09-22 Medline Industries, Inc. Prefilled container systems
LT3679922T (lt) 2012-06-01 2021-10-25 Novartis Ag Švirkštas
AU2013100070B4 (en) * 2012-07-03 2013-04-04 Novartis Ag Use of device
AU2012101677B4 (en) 2012-07-03 2012-12-20 Novartis Ag Device
JOP20200175A1 (ar) 2012-07-03 2017-06-16 Novartis Ag حقنة
US20160015898A1 (en) * 2013-03-01 2016-01-21 Sio2 Medical Products, Inc. Plasma or cvd pre-treatment for lubricated pharmaceutical package, coating process and apparatus

Also Published As

Publication number Publication date
EP3470058A1 (fr) 2019-04-17
PL3656373T3 (pl) 2022-06-20
EP3685826B1 (fr) 2021-11-03
ES2912848T3 (es) 2022-05-30
BR112014032990A2 (pt) 2018-03-06
CN111249062A (zh) 2020-06-09
KR102443606B9 (ko) 2024-12-18
KR102299177B1 (ko) 2021-09-08
US20140012227A1 (en) 2014-01-09
BR112014032990B1 (pt) 2022-01-04
HUE055227T2 (hu) 2021-11-29
CH706741A2 (de) 2014-01-15
US9220631B2 (en) 2015-12-29
KR102395557B1 (ko) 2022-05-09
PT2869813T (pt) 2019-02-27
MA37740B2 (fr) 2020-10-28
KR102299177B9 (ko) 2024-12-18
HRP20211216T1 (hr) 2021-10-29
KR20220062681A (ko) 2022-05-17
PH12014502785A1 (en) 2015-02-02
HK1188404A1 (en) 2014-05-02
HRP20220535T1 (hr) 2022-07-08
IL272915B (en) 2021-02-28
ES2712152T3 (es) 2019-05-09
AR090059A1 (es) 2014-10-15
KR20220130821A (ko) 2022-09-27
MX2014015743A (es) 2015-07-23
CN112972828A (zh) 2021-06-18
HUE042652T2 (hu) 2019-07-29
HRP20220083T1 (hr) 2022-04-15
CA2803566A1 (fr) 2014-01-03
JP6313038B2 (ja) 2018-04-18
DE202013000688U1 (de) 2013-03-05
EP2869813B1 (fr) 2018-11-21
PE20150196A1 (es) 2015-03-02
EP3381444B1 (fr) 2021-05-19
ES2882254T3 (es) 2021-12-01
SG11201408261UA (en) 2015-01-29
DK2869813T3 (en) 2019-03-18
NZ702980A (en) 2017-06-30
EP2869813A1 (fr) 2015-05-13
GT201400300A (es) 2015-10-15
TWI632920B (zh) 2018-08-21
PL3381444T3 (pl) 2021-11-22
SI3685826T1 (sl) 2022-02-28
CH706741B1 (de) 2014-02-14
SI3381444T1 (sl) 2021-09-30
PL3685826T3 (pl) 2022-03-21
EP3381444A1 (fr) 2018-10-03
EP3656373A1 (fr) 2020-05-27
DK3381444T3 (da) 2021-08-09
JP5744927B2 (ja) 2015-07-08
KR20210156865A (ko) 2021-12-27
LT3381444T (lt) 2021-08-25
ECSP15004005A (es) 2018-10-31
FR2983077A1 (fr) 2013-05-31
KR20230013282A (ko) 2023-01-26
KR20200029611A (ko) 2020-03-18
KR102487296B9 (ko) 2024-12-30
MY164536A (en) 2017-12-29
MA37740A1 (fr) 2016-11-30
CN104427972A (zh) 2015-03-18
EP3656373B1 (fr) 2022-02-16
KR102395557B9 (ko) 2024-12-18
JOP20200175A1 (ar) 2017-06-16
BR122020020290B1 (pt) 2022-04-05
IL272915A (en) 2020-04-30
KR102341670B1 (ko) 2021-12-22
JO3655B1 (ar) 2020-08-27
KR102443606B1 (ko) 2022-09-14
MX358323B (es) 2018-08-14
PL2869813T3 (pl) 2019-05-31
CL2014003619A1 (es) 2015-10-02
TN2014000517A1 (en) 2016-03-30
IL236296B (en) 2020-04-30
SI2869813T1 (sl) 2019-04-30
TW201402152A (zh) 2014-01-16
JP2014028114A (ja) 2014-02-13
KR20150030216A (ko) 2015-03-19
AU2013201624A1 (en) 2014-01-23
LT3685826T (lt) 2022-02-10
IL236296A0 (en) 2015-02-26
CN110115657A (zh) 2019-08-13
CY1124431T1 (el) 2022-07-22
KR102092427B1 (ko) 2020-04-17
EA201590139A1 (ru) 2015-07-30
ES2906812T3 (es) 2022-04-20
KR20210113413A (ko) 2021-09-15
EP3685826A1 (fr) 2020-07-29
DK3685826T3 (da) 2022-02-14
LT3656373T (lt) 2022-05-10
JP2014087678A (ja) 2014-05-15
ZA201409411B (en) 2015-11-25
KR102341670B9 (ko) 2024-12-18
CY1121497T1 (el) 2020-05-29
HUE057746T2 (hu) 2022-06-28
CO7151483A2 (es) 2014-12-29
PH12014502785B1 (en) 2015-02-02
HRP20190300T1 (hr) 2019-04-05
WO2014005728A1 (fr) 2014-01-09
LT2869813T (lt) 2019-03-12
DK3656373T3 (da) 2022-05-16
SI3656373T1 (sl) 2022-06-30
EA031583B1 (ru) 2019-01-31
KR102487296B1 (ko) 2023-01-13

Similar Documents

Publication Publication Date Title
FR2983077B1 (fr) Seringue
JOP20180102B1 (ar) مركب صيدلاني
EA201590173A1 (ru) Иммуноконъюгаты, содержащие антитела к cd22
MA33936B1 (fr) Antidotes pour anticoagulants
GT201400279A (es) Jeringa
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
PH12014502406A1 (en) Anti-il-23p19 antibodies
IN2015DN03029A (fr)
IT1404931B1 (it) Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
FR2975600B1 (fr) Agents pour le traitement de tumeurs
FR2995713B1 (fr) Ecran d'affichage, en particulier pour autostereoscopie.
CL2013000069A1 (es) Compuestos derivados de heterociclos fusionados, moduladores s1p; composicion farmaceutica; y uso en enfermedades neurodegenerativas.
MA42166A1 (fr) Seringue
MA34978B1 (fr) Antidotes pour anticoagulants
EA201590651A1 (ru) Фармацевтическая композиция, содержащая ребамипид
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
MA39108A1 (fr) Nouveau composé pour le traitement de l'hypoglycémie sévère
EA201301355A1 (ru) Композиция и таблетка, содержащая ралтегравир
CY1125162T1 (el) Συριγγα
IN2015KN00386A (fr)
UA78360U (en) Use of 1-[n-(isononyl-2-hydroxybenzolmethan)-1-(2-ethylamine)-2-(alkenyl oleinic acid)-4,5-dihydro-1h-imidazolin-dioleate as antioxidant and detergent additive for hydrocarbon adsorbents
UA105703C2 (uk) 7-бром-5-феніл-3-ариламіно-1,2-дигідро-3н-1,4-бенздіазепін-2-они як анальгетичні агенти
UA78284U (en) 5,11- dibenzyl -8-thioxo-13-(2-chlorophenyl)-3,5,7,11- tetraazatricyclo[7.3.1.02,7]tridec-2-ene-1,9-dicarbonitrile
TN2014000207A1 (en) Anti il-36r antibodies

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

RT Complete renunciation

Effective date: 20221121